What is CADASIL?

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a rare, inherited genetic disorder affecting the small blood vessels of the human brain with recurrent strokes, cognitive decline, and other neurological symptoms due to damage caused in a white matter. However, medical researchers and health experts hold the NOTCH3 gene responsible for CADASIL.

What are other genetic stroke conditions?

In addition to CADASIL, other genetic conditions linked to stroke include MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes), Fabry disease, and Hereditary Hemorrhagic Telangiectasia (HHT) which are speculated by doctors to predispose individuals to strokes, either by damaging patient's blood vessels or altering blood flow in his brain.

What are the symptoms of CADASIL?

• Symptoms of CADASIL often appear between the ages of 30 and 50 and include:-
• Recurrent ischemic strokes (caused by reduced blood flow)
• Severe migraines with aura
• Cognitive decline and dementia
• Mood disturbances like depression
• Subcortical infarcts (small areas of dead tissue caused by lack of blood)
• Leukoencephalopathy (white matter changes seen on imaging)

What causes CADASIL and other genetic stroke conditions?

CADASIL is caused generally by mutations in the NOTCH3 gene on chromosome 19, which affects the smooth muscle cells in the brain’s small arteries while other genetic stroke conditions originate from mutations in more diverse genes affecting blood vessels or metabolic pathways that may include MELAS, caused by mutations in mitochondrial DNA, and Fabry disease resulting from mutations in the GLA gene that leads to enzyme deficiencies, causing vascular problems to the individuals.

How is CADASIL diagnosed?

Diagnosis of CADASIL starts with a comprehensive clinical evaluation and family history of the patient, including imaging tests such as MRI to observe and assess characteristic white matter changes as well as the genetic test to confirm the mutation in the NOTCH3 gene for CADASIL. Moreover, skin biopsies may also be conducted as one of the best diagnostic options by doctors to see the abnormal accumulation of Granular Osmophilic Material (GOM) in blood vessels.

What tests are used to diagnose other genetic stroke conditions?

Following are additional diagnostic options to be used to check the genetic stroke conditions of the patients:-

• MELAS is diagnosed through a combination of genetic testing and muscle biopsy.
• Fabry disease is identified through enzyme assays and genetic testing for GLA mutations.
• Hereditary Hemorrhagic Telangiectasia is diagnosed based on clinical features and genetic tests.

How is CADASIL treated?

There is no cure for CADASIL, so treatment focuses on managing symptoms and preventing strokes. Antiplatelet medications like aspirin may be used to reduce stroke risk, and migraines can be treated with standard migraine therapies. Cognitive rehabilitation and therapy may help manage memory and cognitive issues. It is important to avoid smoking and control blood pressure to minimize stroke risk.

How are other genetic stroke conditions treated?

Management varies:-

• MELAS is treated with supportive care and supplements like coenzyme Q10 and L-arginine to help improve mitochondrial function.
• Fabry disease can be treated with enzyme replacement therapy (ERT) to reduce vascular complications.
• HHT management involves treating vascular malformations and controlling bleeding risks.

Can CADASIL be prevented?

Since CADASIL is a genetic disorder, it cannot be prevented. However, managing risk factors like high blood pressure, smoking, and unhealthy lifestyles can reduce the risk of stroke and other complications. Genetic counseling is essential for affected families to understand the inheritance pattern and the potential risk to offspring.

How can other genetic stroke conditions be prevented?

Prevention of stroke in genetic conditions involves careful management of symptoms, lifestyle modifications, and regular medical monitoring. For example, enzyme replacement therapy in Fabry disease can prevent complications, and lifestyle modifications in MELAS can help manage mitochondrial dysfunction.

What is the prognosis for people with CADASIL?

The prognosis for CADASIL varies, but many patients experience a progressive decline in cognitive and physical abilities. Recurrent strokes can lead to significant disability, and as the disease progresses, patients may develop dementia. Life expectancy may be shortened, particularly in cases of severe stroke or other complications.

What is the prognosis for other genetic stroke conditions?

Prognosis depends on the condition:-

• MELAS often results in progressive neurological decline.
• Fabry disease can be managed effectively with enzyme replacement therapy, improving the patient’s quality of life.
• HHT has a variable prognosis, depending on the severity of vascular complications.

How can individuals with CADASIL live with the condition?

Living with CADASIL involves managing symptoms and preventing further damage. Patients benefit from regular monitoring by neurologists and other specialists. Physical therapy, occupational therapy, and cognitive rehabilitation can help maintain quality of life. Emotional and psychological support is also essential due to the mental health impacts of the condition.

How can individuals with genetic stroke conditions manage daily life?

Patients with conditions like MELAS or Fabry disease may require long-term medical care and therapy to manage their symptoms. Support from a multidisciplinary team, including genetic counselors, neurologists, and rehabilitation specialists, can enhance daily functioning and overall well-being.

Why Tender Palm Super-Specialty Hospital for ‘Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)’ and Other Genetic Stroke Conditions?

Tender Palm Super-Specialty Hospital, owned and operated by some of the nation’s most esteemed doctors, is renowned for its expertise in managing complex neurological and cerebrovascular conditions. With a team of highly specialized neurologists, neurosurgeons, and geneticists skilled in diagnosing and treating genetic stroke disorders like Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), the hospital has become a center of excellence in cerebrovascular care in Gomtinagar, Lucknow (UP)-India.

The Cerebrovascular Center at Tender Palm Super-Specialty Hospital offers cutting-edge diagnostic tools such as MRI with advanced neuroimaging techniques and genetic testing to accurately identify CADASIL and other genetic stroke conditions like MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes), Fabry disease, and Hereditary Hemorrhagic Telangiectasia (HHT).

Our multidisciplinary approach brings together vascular neurologists, neuro-geneticists, and rehabilitation specialists to provide comprehensive care for patients with genetic stroke syndromes. Whether it’s managing recurrent strokes, cognitive decline, or other neurological symptoms associated with CADASIL, Tender Palm delivers personalized treatment plans tailored to each patient’s specific condition.

Equipped with the latest in medical technology and infrastructure, including 3 Tesla MRI, neurovascular interventional suites, and genetic diagnostic laboratories, Tender Palm Super-Specialty Hospital offers unparalleled medical care for genetic stroke conditions, ensuring patients receive the highest standard of treatment.

To seek an expert consultation for CADASIL or any other genetic cerebrovascular condition:-

Call us at +91-9076972161
Email at care@tenderpalm.com

Request a Call Back